Digestive Medicine Tablets
Micro-organisms called microflora play a healthy role in the digestive tract, maintaining the balance between helpful and harmful micro-organisms. Microflora help the body utilize nutrients, enzymes and vitamins. As the body ages and is exposed to digestive disorders, antibiotics and even meat, the levels of microflora in our body decreases and limits our digestive ability. Through natural medicine, you can stimulate and protect these healthy micro-organisms and improve digestion overall.
Digestive medicine is a collective term for the several different medical disciplines that address health issues related to the gastrointestinal. Any procedure or practice that is connected with treating parts of the body from the mouth to the anus can be considered part of this broad category. Within the field of digestive medicine, health care professionals often choose specialties that allow them to focus on a given section of the overall digestive system.
Some of the products/medicine for digestion are:
Hajmola tablets
Pudin hara
Gelusil antacid
Digene
ENO
Lactaid
Digestive enzymes
In some cases, other organs may also be considered within the scope of digestive medicine. For example, the pancreas and liver are often included in this field of medical expertise. The bile ducts and the gallbladder are also often considered important to the study of digestive disorders.
Perhaps the most easily recognized practitioners of digestive medicine are known as gastroenterologists. Health professionals who pursue this specialty of medicine undergo a rigid educationand training process.
Along with the eight years of premedical and medical training that is required of most doctors, thegastroenterologist will also undergo a year long internship, then spend an additional three years as a resident of internal medicine. After that, the new specialist will begin a two-year residency that is directly related to gastroenterology.
Within the broad range of digestive medicine, it is possible to practice in several different ways. Some specialists prefer to limit their practice to diagnosing and attempting to heal people suffering with various types of digestive problems. This may be accomplished by specializing in particular surgical procedures, or using other methods to bring about healing. A health professional taking this hands on approach may work exclusively in a hospital setting, or also maintain a private practice.
Digestive problems such as constipation and acidity are likely to rise. In addition to this, lack of basic amenities, such as clean water and sanitary conditions in many rural and semi-urban parts of India, will give further impetus to growth, as these are the main causes of diarrhea.
Digestive medicine is a collective term for the several different medical disciplines that address health issues related to the gastrointestinal. Any procedure or practice that is connected with treating parts of the body from the mouth to the anus can be considered part of this broad category. Within the field of digestive medicine, health care professionals often choose specialties that allow them to focus on a given section of the overall digestive system.
Some of the products/medicine for digestion are:
Hajmola tablets
Pudin hara
Gelusil antacid
Digene
ENO
Lactaid
Digestive enzymes
In some cases, other organs may also be considered within the scope of digestive medicine. For example, the pancreas and liver are often included in this field of medical expertise. The bile ducts and the gallbladder are also often considered important to the study of digestive disorders.
Perhaps the most easily recognized practitioners of digestive medicine are known as gastroenterologists. Health professionals who pursue this specialty of medicine undergo a rigid educationand training process.
Along with the eight years of premedical and medical training that is required of most doctors, thegastroenterologist will also undergo a year long internship, then spend an additional three years as a resident of internal medicine. After that, the new specialist will begin a two-year residency that is directly related to gastroenterology.
Within the broad range of digestive medicine, it is possible to practice in several different ways. Some specialists prefer to limit their practice to diagnosing and attempting to heal people suffering with various types of digestive problems. This may be accomplished by specializing in particular surgical procedures, or using other methods to bring about healing. A health professional taking this hands on approach may work exclusively in a hospital setting, or also maintain a private practice.
Growth in digestive remedies in 2008 was led by urban consumers. Due to a growing economy and more hectic lifestyles, urban consumers increasingly skipped meals and ate out in sometimes unhygienic fast food outlets.
Increasing stress led to constipation, diarrhoea and acidity, especially among young working adults. As a result, demand for digestive remedies was buoyant. In addition to this, lack of intake of nutrients in the form of fruits or dietary supplements further pushed growth.
Heightened marketing activities by Dabur India Ltd for Hajmola drove digestive enzymes growth. Changes in positioning ensured that consumers perceived Hajmola as a must-have after every meal.
For child-specific indigestion and heartburn remedies consumers started moving towards anti-spasmodic remedies.
The value share of herbal/traditional products rose marginally in 2008, having declined in previous years. Dabur India Ltd continued to be the leading player in this area, with brands such as Hajmola and Pudin Hara.
Due to the belief that standard/allopathic products have greater efficacy than their herbal/traditional counterparts, consumers generally prefer taking standard/allopathic products when it comes to treating severe bouts of acidity and other digestive ailments to get instant relief. However, consumers who take digestive remedies on a regular basis often prefer herbal/traditional products, due to their being less susceptible to side effects.
Within indigestion remedies, the fastest growing type is digestive enzymes. Due to their positioning as a easy to take and without a medicinal taste, consumers are more comfortable using digestive enzymes on an everyday basis, unlike antacids which are positioned primarily as medicines. Hajmola’s tangy taste has endeared this brand to consumers from all age groups.
Digestive ailments have risen, as consumers are rarely having a balanced diet, with regular intake of cereals, fruits or other dietary supplements. This trend has positively affected sales of antacids, digestive enzymes, laxatives and diarrhoeal remedies.
UTC sales remained high in digestive remedies in 2008. Laxatives, diarrhoeal remedies, H2 blockers, motion sickness remedies and child specific products are where most UTC sales are seen. Brands such as Dulcolax, Cremaffin, Depandal and Stemetil enjoy long-standing brand loyalty, due to which they have virtually become household names and are freely sold without prescriptions
Increasing stress led to constipation, diarrhoea and acidity, especially among young working adults. As a result, demand for digestive remedies was buoyant. In addition to this, lack of intake of nutrients in the form of fruits or dietary supplements further pushed growth.
Heightened marketing activities by Dabur India Ltd for Hajmola drove digestive enzymes growth. Changes in positioning ensured that consumers perceived Hajmola as a must-have after every meal.
For child-specific indigestion and heartburn remedies consumers started moving towards anti-spasmodic remedies.
The value share of herbal/traditional products rose marginally in 2008, having declined in previous years. Dabur India Ltd continued to be the leading player in this area, with brands such as Hajmola and Pudin Hara.
Due to the belief that standard/allopathic products have greater efficacy than their herbal/traditional counterparts, consumers generally prefer taking standard/allopathic products when it comes to treating severe bouts of acidity and other digestive ailments to get instant relief. However, consumers who take digestive remedies on a regular basis often prefer herbal/traditional products, due to their being less susceptible to side effects.
Within indigestion remedies, the fastest growing type is digestive enzymes. Due to their positioning as a easy to take and without a medicinal taste, consumers are more comfortable using digestive enzymes on an everyday basis, unlike antacids which are positioned primarily as medicines. Hajmola’s tangy taste has endeared this brand to consumers from all age groups.
Digestive ailments have risen, as consumers are rarely having a balanced diet, with regular intake of cereals, fruits or other dietary supplements. This trend has positively affected sales of antacids, digestive enzymes, laxatives and diarrhoeal remedies.
UTC sales remained high in digestive remedies in 2008. Laxatives, diarrhoeal remedies, H2 blockers, motion sickness remedies and child specific products are where most UTC sales are seen. Brands such as Dulcolax, Cremaffin, Depandal and Stemetil enjoy long-standing brand loyalty, due to which they have virtually become household names and are freely sold without prescriptions
There is another important approach to digestive medicine. Rather than focusing on utilizing current tools and strategies to treat people who are dealing with some type of digestion problems, the health care professional may choose to focus on research. This approach is extremely important to the process of advancing the efficacy and scope of treatment related to the practice of gastroenterology. Without the work of dedicated researchers, many of the techniques and medications in common use today would never have been developed, leaving many people to suffer through a great deal of unnecessary pain.
As with most forms of modern medicine, digestive medicine is not a static healing technique. Ongoing research helps to bring about new ways to diagnose and deal with various types of digestive disorders each year. For people who deal with the pain associated with some part of the gastrointestinal tract, this ongoing evolution means that the origin of their pain is identified sooner, and the treatments that follow are likely to ease the discomfort and restore health in less time, and with fewer side effects.
Hajmola is a digestive medicine tablet manufactured by Dabur in India. Its consists of a variety of traditional Ayurvedic Indian herbs, and is supposed to control dyspepsia, ease in digestion and control flatulence.
Hajmola is the market leader in the digestive tablets segment in India with 75% share of the Indian market
Increasingly busy lifestyles, irregular eating habits, lack of exercise and poor nutrition in meals will continue to be the main drivers of growth in sales of digestive remedies over the forecast period.As with most forms of modern medicine, digestive medicine is not a static healing technique. Ongoing research helps to bring about new ways to diagnose and deal with various types of digestive disorders each year. For people who deal with the pain associated with some part of the gastrointestinal tract, this ongoing evolution means that the origin of their pain is identified sooner, and the treatments that follow are likely to ease the discomfort and restore health in less time, and with fewer side effects.
Hajmola is a digestive medicine tablet manufactured by Dabur in India. Its consists of a variety of traditional Ayurvedic Indian herbs, and is supposed to control dyspepsia, ease in digestion and control flatulence.
Hajmola is the market leader in the digestive tablets segment in India with 75% share of the Indian market
| According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), most foods that contain carbohydrates can cause gas, and fats and proteins cause little gas. Foods that cause gas include raffinose - a complex sugar found in beans, cabbage, Brussels sprouts, broccoli, asparagus, other vegetables, and whole grains. lactose - a natural sugar found in milk and milk products, such as cheese and ice cream, and in processed foods, such as bread, cereal, and salad dressing. fructose - a sugar found in onions, artichokes, pears, and wheat, and is also used as a sweetener in some soft drinks and fruit drinks. sorbitol - a sugar found naturally in fruits, including apples, pears, peaches, and prunes, and is also used as an artificial sweetener in many dietetic foods and sugarfree candies and gums. starches - most starches, including potatoes, corn, noodles, and wheat produce gas as they are broken down in the large intestine. (Rice is the only starch that does not cause gas.) soluble fiber - fiber that dissolves easily in water and takes on a soft, gel-like texture in the intestines, and is found in oat bran, beans, peas, and most fruits. Insoluble fiber - fiber, such as that found in wheat bran and some vegetables, which passes essentially unchanged through the intestines and produces little gas. |
Digestive problems such as constipation and acidity are likely to rise. In addition to this, lack of basic amenities, such as clean water and sanitary conditions in many rural and semi-urban parts of India, will give further impetus to growth, as these are the main causes of diarrhea.
The forecast period is expected to see growth a lot higher than that of the review period in constant value terms.
Growth will be driven by increasing UTC consumption of proton pump inhibitors, antiflatulents, IBS treatments and H2 blockers. Consumers are expected to turn to advanced drugs like these in the hope of getting faster and long lasting relief from various digestive ailments.
Growth will be driven by increasing UTC consumption of proton pump inhibitors, antiflatulents, IBS treatments and H2 blockers. Consumers are expected to turn to advanced drugs like these in the hope of getting faster and long lasting relief from various digestive ailments.
In the short term, growth in 2009 is expected to be marginally stronger than that in 2008, in spite of the economic downturn in India. Consumption of digestive remedies is expected to increase in line with a rise in population, which will naturally widen the consumer base.
The review period saw many yoga centers being established in urban centers. Yoga is frequently touted as an effective way to control digestive ailments. If a “yoga revolution” does sweep across the country, growth in digestive remedies will again be negatively affected.
Digestive enzymes are set to see the strongest growth over the forecast period, of 53% in constant value terms. Growth will be driven to a significant extent by Dabur India Ltd increasing penetration through aggressive marketing and promotional activities. Child-specific indigestion and heartburn remedies are expected to see the slowest growth between 2008 and 2013, of just 5% in constant value terms.
Fibotab is expected to perform extremely well in the short term. The brand is expected to see success based on its multipurpose positioning as well as the fact that it does not need to be mixed with water, unlike Isabgol. On the other hand, Benefiber is not expected to do well, because of its high price and a lack of promotion by Novartis India Ltd.
Companies might opt to position their products as meal supplements, instead of medicines, to take advantage of the growing trend to consume digestive remedies on a regular basis. Furthermore, companies will look to rural areas to drive further growth in sales, as urban areas are highly saturated when it comes to products such as antacids, diarrhoeal remedies and laxatives. Promotional activities are likely to include tying up with additional distributors, and conducting road shows and awareness programmes
Dabur India Ltd led sales of digestive remedies in India in 2008. The company increased its value share to 26%, making it the fastest growing company in digestive remedies. Sales of Halmola were good while the sales of Pudin Hara were static due to an exceptionally short summer. The second placed manufacturer in 2008 was Abbott India Ltd, with its leading antacid brand, Digene.
Sales of Cadila Healthcare Ltd, the marketer of best-selling laxative Dulcolax, have come under increasing pressure from the brand Duphalac, from Solvay Pharma Ltd. Consumers have shown a preference for lactulose-based brands, such as Duphalac, as they tend to be gentler on the stomach than bisacodyl-based brands, such as Dulcolax.
Changing consumer preferences also led to sales of GlaxoSmithKline Pharmaceuticals Ltd and RPG Life Sciences Ltd in diarrhoeal remedies coming under pressure from Rx drugs, such as Cifran CT, from Ranbaxy Laboratories Ltd. Unlike brands such as Depandal, Lomotil and Lomofen, which simply provide relief from diarrhoea, drugs such as Cifran CT not only address diarrhoea in a patient, but also provide a more holistic benefit by working on the intestines and digestive system in general.
Torrent Pharmaceuticals Ltd launched Fibotab in late 2007. The brand uses calcium polycarbophil as its API, and thus not only controls diarrhoea, but also treats constipation, thus making it a truly multipurpose drug. The brand has been positioned as better alternative to Isabgol.
Novartis India ltd launched a new product Benefiber in 2008. A wheat dextrin-based laxative, the brand’s largest selling point is that it does not thicken and can be mixed with any beverage.
Digestive remedies remained quite fragmented in 2008. Besides Dabur India Ltd and Abbott India Ltd, no other company managed to achieve a value share of more than 10%. Companies such as Pfizer Ltd, GlaxoSmithKline Pharmaceuticals Ltd and TTK Pharma Ltd lag behind with shares of around 4% to 5% each.
Eno Digesure was launched by GlaxoSmithKline Consumer Healthcare Ltd in December 2007
Refreances : Wikipedia , Exportersindia.net
The review period saw many yoga centers being established in urban centers. Yoga is frequently touted as an effective way to control digestive ailments. If a “yoga revolution” does sweep across the country, growth in digestive remedies will again be negatively affected.
Digestive enzymes are set to see the strongest growth over the forecast period, of 53% in constant value terms. Growth will be driven to a significant extent by Dabur India Ltd increasing penetration through aggressive marketing and promotional activities. Child-specific indigestion and heartburn remedies are expected to see the slowest growth between 2008 and 2013, of just 5% in constant value terms.
Fibotab is expected to perform extremely well in the short term. The brand is expected to see success based on its multipurpose positioning as well as the fact that it does not need to be mixed with water, unlike Isabgol. On the other hand, Benefiber is not expected to do well, because of its high price and a lack of promotion by Novartis India Ltd.
Companies might opt to position their products as meal supplements, instead of medicines, to take advantage of the growing trend to consume digestive remedies on a regular basis. Furthermore, companies will look to rural areas to drive further growth in sales, as urban areas are highly saturated when it comes to products such as antacids, diarrhoeal remedies and laxatives. Promotional activities are likely to include tying up with additional distributors, and conducting road shows and awareness programmes
Dabur India Ltd led sales of digestive remedies in India in 2008. The company increased its value share to 26%, making it the fastest growing company in digestive remedies. Sales of Halmola were good while the sales of Pudin Hara were static due to an exceptionally short summer. The second placed manufacturer in 2008 was Abbott India Ltd, with its leading antacid brand, Digene.
Sales of Cadila Healthcare Ltd, the marketer of best-selling laxative Dulcolax, have come under increasing pressure from the brand Duphalac, from Solvay Pharma Ltd. Consumers have shown a preference for lactulose-based brands, such as Duphalac, as they tend to be gentler on the stomach than bisacodyl-based brands, such as Dulcolax.
Changing consumer preferences also led to sales of GlaxoSmithKline Pharmaceuticals Ltd and RPG Life Sciences Ltd in diarrhoeal remedies coming under pressure from Rx drugs, such as Cifran CT, from Ranbaxy Laboratories Ltd. Unlike brands such as Depandal, Lomotil and Lomofen, which simply provide relief from diarrhoea, drugs such as Cifran CT not only address diarrhoea in a patient, but also provide a more holistic benefit by working on the intestines and digestive system in general.
Torrent Pharmaceuticals Ltd launched Fibotab in late 2007. The brand uses calcium polycarbophil as its API, and thus not only controls diarrhoea, but also treats constipation, thus making it a truly multipurpose drug. The brand has been positioned as better alternative to Isabgol.
Novartis India ltd launched a new product Benefiber in 2008. A wheat dextrin-based laxative, the brand’s largest selling point is that it does not thicken and can be mixed with any beverage.
Digestive remedies remained quite fragmented in 2008. Besides Dabur India Ltd and Abbott India Ltd, no other company managed to achieve a value share of more than 10%. Companies such as Pfizer Ltd, GlaxoSmithKline Pharmaceuticals Ltd and TTK Pharma Ltd lag behind with shares of around 4% to 5% each.
Eno Digesure was launched by GlaxoSmithKline Consumer Healthcare Ltd in December 2007
Refreances : Wikipedia , Exportersindia.net
No comments:
Post a Comment